Similarly, Ramanand et al. [45] recently reported that the impeded expression of VPS53, FAM57A, and GEMIN4 genes might cause the increased biochemical recurrence risk for prostate cancer patients. This evidence concerns the gene GEMIN4 and prostate carcinoma.